Placeholder Banner

Life Sciences Community Joins Rep. Charlie Dent to Discuss State of the Industry and Positive Impact on Pennsylvania

August 18, 2016

WHAT: Roundtable discussion about the life sciences landscape, including the industry’s economic impact on Pennsylvania, the value of innovation, bioscience education opportunities, NIH funding and research best practices. Rep. Charlie Dent and Hon. Jim Greenwood to deliver remarks

WHO:
• Rep. Charlie Dent (R-PA-15)
• Hon. Jim Greenwood, President & CEO, BIO; former PA Congressman
• Mr. Craig Tucker, Vice President, PA BIO • Dr. Keri Donaldson, Founder, Prescient Medicine
• Dr. Ralf Brandt, CEO & Managing Director, vivoPharm
• Dr. Kent Vrana, Professor & Chair, Penn State Dept. of Pharmacology
• Dr. Mel Billingsley, President & CEO, Life Sciences Greenhouse of Central PA
• Ms. Caitlin Orr, Project Coordinator, Hershey Center for Applied Research
• Mr. Nick Magallanes, Director Federal Government Relations, BIO

WHEN: Tuesday, August 23, 2016, 1:30 to 2:30 p.m. (Eastern Time Zone)

WHERE:
Hershey Center for Applied Research
Room 1103
1214 Research Boulevard
Hummelstown, PA 17036  


https://www.bio.org/sites/default/files/SP_Pennsylvania_0.pdf

 

Discover More
Action plan outlines the policies needed to ensure that the biotechnology sector remains a driving force for America’s health, prosperity, national security, and geopolitical strengthWASHINGTON (November 10, 2026) - The Biotechnology Innovation…
Complaint argues HHS and CMS exceeded statutory authority; rule puts patient access, investment in future innovation, and America’s long-term biotechnology leadership at risk.WASHINGTON, DC & SAN DIEGO, CA & SAN FRANCISCO, CA - The…
WASHINGTON, DC (October 28, 2026) – Today, the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) released new national and state-level data on the U.S. bioscience industry’s economic impact…